{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:36:40Z","timestamp":1789385800287,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T00:00:00Z","timestamp":1310688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T00:00:00Z","timestamp":1310688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/cgt.2011.37","type":"journal-article","created":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T10:22:55Z","timestamp":1310725375000},"page":"663-673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32"],"prefix":"10.1038","volume":"18","author":[{"given":"Y","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W J","family":"Storkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,15]]},"reference":[{"key":"BFcgt201137_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2008.08.004","volume":"29","author":"CJ Melief","year":"2008","unstructured":"Melief CJ . Cancer immunotherapy by dendritic cells. Immunity 2008; 29: 372\u2013383.","journal-title":"Immunity"},{"key":"BFcgt201137_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/cgt.2009.33","volume":"16","author":"H Komita","year":"2009","unstructured":"Komita H, Zhao X, Katakam AK, Kumar P, Kawabe M, Okada H et al. Conditional interleukin-12 gene therapy promotes safe and effective anti-tumor immunity. Cancer Gene Ther 2009; 16: 883\u2013891.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201137_CR3","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.4049\/jimmunol.1001294","volume":"185","author":"Y Qu","year":"2010","unstructured":"Qu Y, Chen L, Pardee AD, Taylor JL, Wesa AK, Storkus WJ . Intralesional delivery of dendritic cells engineered to express T-bet promotes protective type 1 immunity and the normalization of the tumor microenvironment. J Immunol 2010; 185: 2895\u20132902.","journal-title":"J Immunol"},{"key":"BFcgt201137_CR4","first-page":"6378","volume":"63","author":"T Tatsumi","year":"2003","unstructured":"Tatsumi T, Huang J, Gooding WE, Gambotto A, Robbins PD, Vujanovic NL et al. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity. Cancer Res 2003; 63: 6378\u20136386.","journal-title":"Cancer Res"},{"key":"BFcgt201137_CR5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","volume":"148","author":"CA Dahl","year":"1992","unstructured":"Dahl CA, Schall RP, He HL, Cairns JS . Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 1992; 148: 597\u2013603.","journal-title":"J Immunol"},{"key":"BFcgt201137_CR6","first-page":"131","volume":"22","author":"SH Kim","year":"2005","unstructured":"Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA . Interleukin-32: a cytokine and inducer of TNF-\u03b1. Immunity 2005; 22: 131\u2013142.","journal-title":"Immunity"},{"key":"BFcgt201137_CR7","doi-asserted-by":"publisher","first-page":"16309","DOI":"10.1073\/pnas.0508237102","volume":"102","author":"MG Netea","year":"2005","unstructured":"Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1\u03b2 and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005; 102: 16309\u201316314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201137_CR8","doi-asserted-by":"publisher","first-page":"R166","DOI":"10.1186\/ar2074","volume":"8","author":"H Shoda","year":"2006","unstructured":"Shoda H, Fujio K, Yamaguchi Y, Okamoto A, Sawada T, Kochi Y et al. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther 2006; 8: R166.","journal-title":"Arthritis Res Ther"},{"key":"BFcgt201137_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1600-065X.2008.00713.x","volume":"226","author":"SA Saenz","year":"2008","unstructured":"Saenz SA, Taylor BC, Artis D . Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 2008; 226: 172\u2013190.","journal-title":"Immunol Rev"},{"key":"BFcgt201137_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4049\/jimmunol.181.1.557","volume":"181","author":"MF Nold","year":"2008","unstructured":"Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH et al. Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 2008; 181: 557\u2013565.","journal-title":"J Immunol"},{"key":"BFcgt201137_CR11","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.4049\/jimmunol.166.6.3837","volume":"166","author":"JF Arrighi","year":"2001","unstructured":"Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C . A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-\u03b1, and contact sensitizers. J Immunol 2001; 166: 3837\u20133845.","journal-title":"J Immunol"},{"key":"BFcgt201137_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1615\/CritRevImmunol.v21.i1-3.120","volume":"21","author":"GK Koski","year":"2001","unstructured":"Koski GK, Lyakh LA, Cohen PA, Rice NR . CD14+ monocytes as dendritic cell precursors: diverse maturation-inducing pathways lead to common activation of NF-\u03baB\/RelB. Crit Rev Immunol 2001; 21: 179\u2013189.","journal-title":"Crit Rev Immunol"},{"key":"BFcgt201137_CR13","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/eji.200324341","volume":"33","author":"CJ Melief","year":"2003","unstructured":"Melief CJ . Mini-review: regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming? Eur J Immunol 2003; 33: 2645\u20132654.","journal-title":"Eur J Immunol"},{"key":"BFcgt201137_CR14","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1073\/pnas.0511233103","volume":"103","author":"LA Joosten","year":"2006","unstructured":"Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006; 103: 3298\u20133303.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201137_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-2249.2007.03439.x","volume":"149","author":"M Shioya","year":"2007","unstructured":"Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S et al. Epithelial overexpression of interleukin-32\u03b1 in inflammatory bowel disease. Clin Exp Immunol 2007; 149: 480\u2013486.","journal-title":"Clin Exp Immunol"},{"key":"BFcgt201137_CR16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jaci.2010.01.016","volume":"125","author":"N Meyer","year":"2010","unstructured":"Meyer N, Zimmermann M, B\u00fcrgler S, Bassin C, Woehrl S, Moritz K et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol 2010; 125: 858\u2013865.","journal-title":"J Allergy Clin Immunol"},{"key":"BFcgt201137_CR17","first-page":"S112","volume":"26","author":"E Csernok","year":"2008","unstructured":"Csernok E, Holle JU, Gross WL . Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis. Clin Exp Rheumatol 2008; 26: S112\u2013S117.","journal-title":"Clin Exp Rheumatol"},{"key":"BFcgt201137_CR18","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.4049\/jimmunol.1000081","volume":"186","author":"JA Zepp","year":"2011","unstructured":"Zepp JA, Nold-Petry CA, Dinarello CA, Nold MF . Protection from RNA and DNA viruses by IL-32. J Immunol 2011; 186: 4110\u20134118.","journal-title":"J Immunol"},{"key":"BFcgt201137_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2567.2010.03377.x","volume":"132","author":"S Lee","year":"2011","unstructured":"Lee S, Kim JH, Kim H, Kang JW, Kim SH, Yang Y et al. Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene. Immunology 2011; 132: 410\u2013420.","journal-title":"Immunology"},{"key":"BFcgt201137_CR20","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1371\/journal.pmed.0030274","volume":"3","author":"M Kundu","year":"2006","unstructured":"Kundu M, Basu J . IL-32: an emerging player in the immune response network against tuberculosis? PLoS Med 2006; 3: e274.","journal-title":"PLoS Med"},{"key":"BFcgt201137_CR21","doi-asserted-by":"publisher","first-page":"RESEARCH0035","DOI":"10.1186\/gb-2002-3-7-research0035","volume":"3","author":"MC Panelli","year":"2002","unstructured":"Panelli MC, Wang E, Phan G, Puhlmann M, Miller L, Ohnmacht GA et al. Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration. Genome Biol 2002; 3: RESEARCH0035.","journal-title":"Genome Biol"},{"key":"BFcgt201137_CR22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1084\/jem.183.4.1357","volume":"183","author":"JI Mayordomo","year":"1996","unstructured":"Mayordomo JI, Loftus DJ, Sakamoto H, De Cesare CM, Appasamy PM, Lotze MT et al. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J Exp Med 1996; 183: 1357\u20131365.","journal-title":"J Exp Med"},{"key":"BFcgt201137_CR23","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.1158\/0008-5472.CAN-08-0387","volume":"68","author":"H Komita","year":"2008","unstructured":"Komita H, Zhao X, Taylor JL, Sparvero LJ, Amoscato AA, Alber S et al. CD8+ T-cell responses against hemoglobin-\u03b2 prevent solid tumor growth. Cancer Res 2008; 68: 8076\u20138084.","journal-title":"Cancer Res"},{"key":"BFcgt201137_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4049\/jimmunol.181.1.104","volume":"181","author":"K Sasaki","year":"2008","unstructured":"Sasaki K, Zhao X, Pardee AD, Ueda R, Fujita M, Sehra S et al. Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo. J Immunol 2008; 181: 104\u2013108.","journal-title":"J Immunol"},{"key":"BFcgt201137_CR25","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V90.4.1594","volume":"90","author":"P Brossart","year":"1997","unstructured":"Brossart P, Bevan MJ . Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 1997; 90: 1594\u20131599.","journal-title":"Blood"},{"key":"BFcgt201137_CR26","doi-asserted-by":"publisher","first-page":"8461","DOI":"10.1158\/0008-5472.CAN-05-0654","volume":"65","author":"J Huang","year":"2005","unstructured":"Huang J, Tatsumi T, Pizzoferrato E, Vujanovic N, Storkus WJ . Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation. Cancer Res 2005; 65: 8461\u20138470.","journal-title":"Cancer Res"},{"key":"BFcgt201137_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/sj.cdd.4402243","volume":"15","author":"AK Wesa","year":"2008","unstructured":"Wesa AK, Storkus WJ . Killer dendritic cells: mechanisms of action and therapeutic implications for cancer. Cell Death Differ 2008; 15: 51\u201357.","journal-title":"Cell Death Differ"},{"key":"BFcgt201137_CR28","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","volume":"181","author":"JI Youn","year":"2008","unstructured":"Youn JI, Nagaraj S, Collazo M, Gabrilovich DI . Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008; 181: 5791\u20135802.","journal-title":"J Immunol"},{"key":"BFcgt201137_CR29","doi-asserted-by":"publisher","first-page":"721s","DOI":"10.1158\/1078-0432.CCR-06-2197","volume":"13","author":"AC Ochoa","year":"2007","unstructured":"Ochoa AC, Zea AH, Hernandez C, Rodriguez PC . Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 2007; 13: 721s\u20137726s.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201137_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","volume":"16","author":"P Serafini","year":"2006","unstructured":"Serafini P, Borrello I, Bronte V . Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 2006; 16: 53\u201365.","journal-title":"Semin Cancer Biol"},{"key":"BFcgt201137_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1359-6101(01)00032-6","volume":"13","author":"MP Colombo","year":"2002","unstructured":"Colombo MP, Trinchieri G . Interleukin-12 in anti-tumor immunity and imunotherapy. Cytokine Growth Factor Rev 2002; 13: 155\u2013168.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFcgt201137_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1517\/14712598.2.5.513","volume":"2","author":"JM Wigginton","year":"2002","unstructured":"Wigginton JM, Wiltrout RH . IL-12\/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside. Expert Opin Biol Ther 2002; 2: 513\u2013524.","journal-title":"Expert Opin Biol Ther"},{"key":"BFcgt201137_CR33","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.161.4.2011","volume":"161","author":"P Hermann","year":"1998","unstructured":"Hermann P, Rubio M, Nakajima T, Delespesse G, Sarfati M . IFN-\u03b1 priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression. J Immunol 1998; 161: 2011\u20132018.","journal-title":"J Immunol"},{"key":"BFcgt201137_CR34","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1073\/pnas.87.13.5183","volume":"87","author":"DR Johnson","year":"1990","unstructured":"Johnson DR, Pober JS . Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium. Proc Natl Acad Sci USA 1990; 87: 5183\u20135187.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201137_CR35","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1073\/pnas.0712381105","volume":"105","author":"MG Netea","year":"2008","unstructured":"Netea MG, Lewis EC, Azam T, Joosten LA, Jaekal J, Bae SY et al. Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci USA 2008; 105: 3515\u20133520.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201137_CR36","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1073\/pnas.1016005108","volume":"108","author":"B Heinhuis","year":"2011","unstructured":"Heinhuis B, Koenders MI, van de Loo FA, Netea MG, van den Berg WB, Joosten LA . Inflammation-dependent secretion and splicing of IL-32\u03b3 in rheumatoid arthritis. Proc Natl Acad Sci USA 2011; 108: 4962.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201137_CR37","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.micinf.2007.01.026","volume":"9","author":"G Auray","year":"2007","unstructured":"Auray G, Lacroix-Lamand\u00e9 S, Mancassola R, Dimier-Poisson I, Laurent F . Involvement of intestinal epithelial cells in dendritic cell recruitment during C. parvum infection. Microbes Infect 2007; 9: 574\u2013582.","journal-title":"Microbes Infect"},{"key":"BFcgt201137_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1084\/jem.188.2.373","volume":"188","author":"MC Dieu","year":"1998","unstructured":"Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, A\u00eft-Yahia S et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998; 188: 373\u2013386.","journal-title":"J Exp Med"},{"key":"BFcgt201137_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.immuni.2006.01.005","volume":"24","author":"M Le Borgne","year":"2006","unstructured":"Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8+ T cell cross-priming in vivo. Immunity 2006; 24: 191\u2013201.","journal-title":"Immunity"},{"key":"BFcgt201137_CR40","first-page":"289","volume":"16","author":"N Cagnard","year":"2005","unstructured":"Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine\/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur Cytokine Netw 2005; 16: 289\u2013292.","journal-title":"Eur Cytokine Netw"},{"key":"BFcgt201137_CR41","doi-asserted-by":"publisher","first-page":"e9458","DOI":"10.1371\/journal.pone.0009458","volume":"5","author":"H Kobayashi","year":"2010","unstructured":"Kobayashi H, Huang J, Ye F, Shyr Y, Blackwell TS, Lin PC . Interleukin-32\u03b2 propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS One 2010; 5: e9458.","journal-title":"PLoS One"},{"key":"BFcgt201137_CR42","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cyto.2009.03.007","volume":"46","author":"H Kobayashi","year":"2009","unstructured":"Kobayashi H, Lin PC . Molecular characterization of IL-32 in human endothelial cells. Cytokine 2009; 46: 351\u2013358.","journal-title":"Cytokine"},{"key":"BFcgt201137_CR43","doi-asserted-by":"publisher","first-page":"17868","DOI":"10.1074\/jbc.M900368200","volume":"284","author":"A Nishida","year":"2009","unstructured":"Nishida A, Andoh A, Inatomi O, Fujiyama Y . Interleukin-32 expression in the pancreas. J Biol Chem 2009; 284: 17868\u201317876.","journal-title":"J Biol Chem"},{"key":"BFcgt201137_CR44","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1164\/rccm.200804-646OC","volume":"178","author":"F Calabrese","year":"2008","unstructured":"Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P et al. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178: 894\u2013901.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFcgt201137_CR45","doi-asserted-by":"publisher","first-page":"e1985","DOI":"10.1371\/journal.pone.0001985","volume":"3","author":"W Li","year":"2008","unstructured":"Li W, Liu Y, Mukhtar MM, Gong R, Pan Y, Rasool ST et al. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One 2008; 3: e1985.","journal-title":"PLoS One"},{"key":"BFcgt201137_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1479-666X(09)80042-5","volume":"7","author":"DP Toomey","year":"2009","unstructured":"Toomey DP, Murphy JF, Conlon KC . COX-2, VEGF and tumour angiogenesis. Surgeon 2009; 7: 174\u2013180.","journal-title":"Surgeon"},{"key":"BFcgt201137_CR47","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.4049\/jimmunol.179.6.3742","volume":"179","author":"F Tian","year":"2007","unstructured":"Tian F, Grimaldo S, Fujita M, Cutts J, Vujanovic NL, Li LY . The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation. J Immunol 2007; 179: 3742\u20133751.","journal-title":"J Immunol"},{"key":"BFcgt201137_CR48","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1158\/0008-5472.CAN-08-4709","volume":"69","author":"J Ozao-Choy","year":"2009","unstructured":"Ozao-Choy J, Ma G, Kao J, Wang GX, Meseck M, Sung M et al. The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res 2009; 69: 2514\u20132522.","journal-title":"Cancer Res"},{"key":"BFcgt201137_CR49","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1084\/jem.194.6.823","volume":"194","author":"RP Sutmuller","year":"2001","unstructured":"Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001; 194: 823\u2013832.","journal-title":"J Exp Med"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201137","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T04:17:20Z","timestamp":1686197840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,15]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["BFcgt201137"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2011.37","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,15]]},"assertion":[{"value":"12 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}